financetom
Business
financetom
/
Business
/
TAT Technologies Reports Public Offering of Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TAT Technologies Reports Public Offering of Shares
May 28, 2025 3:10 PM

05:58 PM EDT, 05/28/2025 (MT Newswires) -- TAT Technologies ( TATT ) reported late Wednesday the launch of a public offering, with about 1.63 million shares coming from the company and some 2.53 million shares from investors FIMI Opportunity V and FIMI Israel Opportunity Five.

TAT and the shareholders plan to grant underwriters, including Stifel, Nicolaus & Company and Truist Securities, an option to buy up to an additional 242,298 and 380,202 shares, respectively.

The company said it plans to use the net proceeds for general corporate purposes.

Shares of TAT were down about 5.9% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aviat Networks Acquires 4RF to Expand Wireless Communications Business
Aviat Networks Acquires 4RF to Expand Wireless Communications Business
Jul 3, 2024
04:25 AM EDT, 07/03/2024 (MT Newswires) -- Aviat Networks ( AVNW ) said late Tuesday it has acquired 4RF, a provider of industrial wireless communications systems. Financial terms of the acquisition were not disclosed. This acquisition provides Aviat with access to the narrowband connectivity and cellular router markets, the company said. Aviat expects the addition of 4RF's business to be...
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Jul 3, 2024
04:15 AM EDT, 07/03/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Wednesday the European Commission has approved Dupixent as an additional maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, or COPD, a respiratory disease that damages the lungs. The decision marks the first Dupixent approval worldwide for COPD patients, the companies...
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Jul 3, 2024
In a significant development in the battle against Alzheimer’s disease, the U.S. Food and Drug Administration (FDA) has approved Eli Lilly ( LLY ) and Company’s Alzheimer’s treatment, “Kisunla.” What Happened: As per the official press release on Tuesday, Kisunla (donanemab-azbt), a once-monthly IV infusion injection, is intended for adults in the early symptomatic stages of Alzheimer’s disease, including those...
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Jul 3, 2024
04:16 AM EDT, 07/03/2024 (MT Newswires) -- Futu Holdings ( FUTU ) said early Wednesday its wealth management business surpassed $10 billion in assets under management. The company also said its fully-owned subsidiary, Moomoo Securities Malaysia, recently received approval from the Federation of Investment Managers Malaysia to distribute wealth management products in the country. Price: 65.89, Change: -0.13, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved